CTLA-4 VARIANTEN

European patent · EP3207938 · In force

Register entry

Publication number
EP3207938
Application number
EP17163638
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 11, 2013
Published
Aug 23, 2017
Granted
Dec 25, 2019
Protection ends at the latest
Mar 10, 2033
Next annual fee due
Mar 31, 2027
IPC classes
C07K 14/705 (2006.01)
A61K 38/00 (2006.01)
Priority
US 201261645686 P 11.05.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Dec 25, 2019

    Granted

    Published in Swissreg on 25.12.2019

Parties

Holder

Medimmune Limited

MedImmune Limited

Milstein Building Granta Park, Cambridge CB21 6GH, GB

Inventor

MINTER, Ralph

Cambridge, Cambridgeshire CB21 6GH, GB

DOUTHWAITE, Julie

Cambridge, CB21 6GH, GB

PRIVESENTZEV, Cyril

Cambridge, CB21 6GH, GB

MOISAN, Jacques

Gaithersburg, Maryland 20878, US

BOWEN, Michael

Gaithersburg, Maryland 20878, US

RUST, Steven

Cambridge, Cambridgeshire CB21 6GH, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.